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CHAPTER I
INTRODUCTION
Calcium plays a critical role in a variety of essential processes
such as excitation, contraction, blood clotting, enzymatic reactions and
as a calcium phosphate complex it serves as the supporting comp'onent
of the vertebrate system.

McLean and Hastings (1935) have describea

the calcium concentration in body fluids as "one of nature's physiological
constant s " .

The interrelationships among the various calcium compart-

ments and the controls operating to maintain the proper balance among
them are poorly understood.
Bone represents by far the largest calcium compartment of the
vertebrate system and it would be expected that any change in its state
would be readily reflected in a change in the other compartments
especially blood.

6

Then, the physiological regulation of blood calcium

would be mediated mainly by those factors that influence the formation
and resorption of bone, namely parathyroid hormone, calcitonin, and
vitamin D.

But there are other factors which have been implicated in

the control of bone metabol1.sm and plasma calcium._

Thyroxine,

corticoids:. estrogens and growth hormone affect bone resorption, blood
and urine calcium and phosphate (Nordin, 1966).

The titers of these

hormones do not change with experimentally induced changes in plasma
calcium.

It is not clear whether their action is a direct or an indirect

- 2 -

one or whether they are of importance in the overall physiological
maintenance of calcium homeostasis.
The importance of the parathyroid glands in the mediation of calcium homeostasis was recognized by MacCallum and Voegtlin (1908) who
showed that the removal of the parathyroid glands caused a marked fall
in serum calcium, and that the tetany associated with the hypocalcemia
could be relieved by administration of calcium salts.

An active para-

thyroid extract able to relieve tetany and restore to normal, the calcium
and phosphate levels in the blood was prepared by Collip and coworkers
who also developed a method for its.

•

bio~ssay

(Collip, 1925; Collip et al.

1925; Collip and Clark, 1925a, b).
Albright an_d Reifenstein ( 1948) considered the primary effect of
parathyroid hormone to be on the phosphate dissolved in the body
fluids.

The hormone would affect the phosphate in such a way as to

make it more readily excreted by the kidneys with a resulting decrease
in serum phosphate level.

Resorption of the hydroxyapatite of bone

would, therefore, increase resulting in an elevated serum calcium •.
According to this hypothesis the administration of parathyroid hormone
results in a rise in serum calcium because of a primary effect on phosphate excretion.
In.the second hypothesis developed by McLean and Urist (1955),

- 3 -

bone was considered as the primary target of parathyroid hormone
action with an indirect effect on the tubular reabsorption of phosphate.
A negative feedback mechanism was proposed to regulate the hormone
secretion.

A low blood calcium titer would evoke an increased para-

thyroid hormone release, which would in turn effect calcium mobilization from bone to raise the serum calcium to the normal level; a high
blood calcium titer would reduce the release of parathyroid hormone
and the consequent bone resorption~
Rasmussen (1961) pointed out that a mechanism of blood calcium

•
,,

regulation based only on the parathyroid· glands and their effect on bone
would lead to wide fluctuations in blood calcium because of the slow
and extended response of bone to parathyroid hormone, by increasing
tubular re absorption of calcium and distal tubular secretion of phos phate.

Rasmussen believed that the kidney may be responsible for the

rapid control of small fluctuations in plasma calcium.

Sanderson et al.

(1960} observed that in intact dogs blood calcium would return to the
initial level within a few hours after it had been raised by the administration of calcium or lowered by the administration of EDTA.

In

parathyroidectomized animals, however, it had not returned to the initial
levels in 24 hours.
During perfusion experiments designed to test the hypothesis of

- 4 and Urist (1955), Copp and Davidson (1961) and Copp et al.
(i961, 1962) obtained results similar to those of Sanderson.

The feed-

back hypothesis could explain the difference. in the response to hypocalcemia. consequent to EDTA administration, between the normal and
parathyroidectomized animals.

Hypocalcemia would stimulate parathyroid

hormone synthesis and release, which in turn would increase calcium
mobilization from bone, .and the blood calcium would return to its initial
level; in parathyroidectomized animals the absence of the parathyroid
glands results in the observed lack of calcium return to its initial level.

•

The time difference for calcium to retur.n to its initial level observed
between the normal and parathyroidectomized animals after induced
hypercalcemia by administration of calcium chloride cannot be explained
by the simple hypothesis that high levels of calcium suppress parathyroid hormone secretion.

If this were so. the response should be

similar in both the normal animal, where parathyroid hormone output
has been inhibited, and in the parathyroidectomized animal, which lacks.
\

parathyroid hormone.

Using the dog as the experimental animal, Copp

et al. (1962) showed that during hypercalcemia the parathyroid glands
produce a hypocalcemic factor. which he named calcitonin.
Hirsch, Gautier and Munson (1963) and Macintyre, Foster and
Kumar (1965) confirmed the existence of a hypocalcemic factor, but

- 5 found that it was secreted by the thyroid glands.

called the thyroid factor. thyrocalcitonin.

Hirsch et al. (1963)

Foster. Macintyre and

pearse (1964) and Pearse (1965) suggested that thyrocalcitonin was
synthesized by the parafollicular cells of the thyroid, and Pearse (1966)
introduced the term C cells (C for calcitonin) for these cells.

Immuno-

fluorescence studies {Bussolati. Carvalheira and Pearse. -1967) have
demonstrated the presence of calcitonin in the C cells of the thyroid
glands of the guinea-pig.

The C cells of the thyroid glands are large.

have an oval nucleus and contain spherical granules in their cytoplasm

•

(Non~dez,

1932).

Matsuzawa and Kurosumi (1967) in a study of the

morphology of the C cells demonstrated that the granules are released
by hypercalcemic stimulation.
In a study of the embryology of the C cells. Carvalheira and

Pearse (1967) established that these cells originate from the last pair
of pharyngeal pouches and are present in all vertebrates except the
cyclostomes. _ In bony fishes. elasmobranchs. amphibia, reptiles and
birds, these cells remain separate from the thyroid glands and form
the ultimobranchial bodies.

It appeared that, at least. in some birds

and reptiles some of these cells migrate ·to the thyroids as evidenced
" -

by extraction of calcitonin from both the ultimobranchial bodies and the
thyroid.

Copp et al. (1967) were able to extract calcitonin from the

---

-

r::
rr

L.
k
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ultimobranchial bodies of chickens and Moseley et al. ( 1968) extracted

·~.:

calcitonin from the ultimobranchial bodies of the chicken, pigeon and

('

the African skink (Mabuya striato).

TheY: .found that in the chicken and

skink most of the calcitonin was found in the ultimobranchial bodies,
whereas in the pigeon it was found in equal amounts in both the
ultimobranchial bodies and thyroid glands.

Clark ( 1968) identified

calcitonin in the ultimobranchial bodies of turtles (Crysemis picta and

'·....
/

Pseudemys scripta).
~

:.. .,

Calcitonin seems to exist in at least four forms, designated alpha,

•

beta, gamma and delta; the four calcitoriins differ in their elution
patterns on Sephadex gels (Gudmundsson, 1967} and the C-terminal
praline of beta calcitonin does not have an amide group.

The a -

calcitonin from porcine thyroid glands has been purified and its amino
acid sequence determined (Potts et al. 1968; Neher et al. 1968).

The

sequence has been confirmed by the chemical synthesis of the polypeptide (Rittel et al. 1968).

The polypeptide has 32 amino acids and a

molecular weight of 3585 (Figure 1).

The pure peptide has an activity

of 200-250 Medical Research Council units/mg dry weight (Kahnt et al.
1968).. One MRC unit is defined in terms of a Standard Preparation,
10 milliunits of which produce a 10% fall in plasma calcium when
administered intravenously in a 150 gm rat (Kumar et al. 1965).

- 7 -
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Cys-Ser-Asn-Leu-Ser-Thr-Cys-Val-Leu1
2
3
4
5
6
7
8
9

Ser-Ala-Tyr-Trp-Arg-Asn-Leu-Asn10 11 12 13 14 15 16 17

Asn-Phe-His-Arg-Phe-Ser-Gly-Met18 19 20 21
22 23 24 25

•

0

//

Gly-Phe-Gly-Pro-Glu-Thr-Pro-C
26 27 28 29 30 31 32
~H
2

FIGURE 1.

AMINO ACID SEQUENCE

OF PORCINE ALPHA-CALCITONIN

'

(Potts et al. 1968).

..

.
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The calcitonin peptide has several distinctive structural features
{Potts et al. 1968).

The single tyrosine and tryptophane residues are

adjacent; the number of charged amino acids is quite low.

There is a

1-7 intrachain disulfide bridge, providing a 23-membered ring at the

amino-terminus.

The carboxyl-terminal amino acid is prolinamide.

The terminal disulfide group and the alpha-carboxyl amide are analogous
structural features found in oxytocin and vasopressin.

What portions of

calcitonin are necessary for biological and immunological activity are
not yet known; however, methionine {residue 25) may be alkylated or
oxidized without loss of biological activ.ity {Brewer et al. 1968).

The

serine, glycine and proline constitute 35% of the amino acid residues
in the molecule; isoleucine is absent {Potts et al. 1967).

There seem to be some species differences with respect to the
chemistry and biological activity of calcitonin.

Tashjian and Munson

(1965} found that antiserum to porcine calcitonin produced in rabbits

neutralized pig and calf calcitonin but had no effect on the activity of
calcitonin from rats, monkeys or man. , Likewise, the difficulty in
demonstrating hypocalcemic activity of porcine calcitonin in man may
be due to differences in the calcitonin o( the two species; in fact human
calcitonin from C cell tumors has been isolated and the amino acid
sequence determined {Neher et al. 1968) and it was found that even

- 9 though the disulfide bridge between position 1 and 7, and the C-terminal
proline amide are the same as in porcine alpha-calcitonin 18 amino
acid residues are "different throughout the. ;molecule.

Arginine and

tryptophane are absent, lysine and isoleucine are found in position 18
and 27 respectively. and methionine changes its place from position 25
to 8.

Pigeon calcitonin seems to be different from porcine calcitonin,

since it has a different elution pattern than porcine calcitonin on
Sephadex (Moseley et al. 1968).

More evidence for species differences

comes from the report that two porcine and one avian (chicken)

•

calcitonin preparations, which had equal· activities in the rat, were found
to differ when tested in the mouse.
[

i·

One porcine and the avian prepara-

tion were ten and five times, respectively, more potent than the other
porcine preparation {Parson and Reynolds, 1968).
Calcitonin acts on both bone and kidney.

Kenny (1964) and Hirsch

I

Voelkel arid Munson ( 1964) showed that calcitonin decreases serum
phosphat,e and that the administration of calcitonin was followed by a
phosphaturia (Kenny and Heiskell, 1965; Milhaud, Moukhtar, Cherion
and Perault, 1966; Robinson, Martin and Macintyre, 1966).

The renal

effect, . however, requires doses 10-100 times higher than those
necessary

to

produce hypocalcemia (Russell and Fleish, 1967).

The

hypophosphateII1ia produced by calcitonin is not entirely due to an in-

~-.
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creased excretion of phosphate, but also to increased phosphate deposition in bone; in fact, hypophosphatemia is still observed in nephrectomized rats (Robinson, Martin, Matthews and Macintyre, 1967).

The

exact nature of the renal effect is not known, and it may be secondary
to increased parathyroid hormone secretion (Stahl et al. 1966).
Several investigators have attempted to clarify the relationship
between calcitonin and parathyroid hormone.

Hirsch et al. (1964)

reported that parathyroidectomy did not affect the hypocalcemic or the
hypophosphatemic response to calcitonin.

..

firmed Hirsch's findings.

Gitelman et al. (1965) con-

Gudmundsson· et al. (1966) observed that after

parathyroidectomy, rats maintained on a normal diet did not exhibit the
hypocalcemic effect of calcitonin but did exhibit the hypophosphatemic
response.

When the parathyroidectomized rats were maintained on a

high calcium, low phosphate diet both the hypocalcemic and hypophosphatemic effects of calcitonin were observed.

. Milhaud et al. (1966),

however, obtained results which showed that parathyroidectomy in rats
maintained on a normal diet abolished only the hypophosphatemic effect.
•.

Stahl and Kenny (1967) have reported that thyroparathyroidectomy in the
dog abolished the hypophosphatemic response of calcitonin, and calcitonin.
administration in the thyroparathyroidectomized dogs caused a relative
hyperphosphatemia.

[

On the other hand, the hyperphosphaturic effect in

- 11 the rat is not abolished by thyroparathyroidectomy (Milhaud et al. 1966)
or parathyroidectomy (Robinson, Martin and Macintyre, 1966).
The hypocalcemic effect of calcitonin. is due to its inhibitory
action on calcium mobilization from bone.

Friedman and Raisz (1965)

studied the effect of calcitonin on isolated embryonic rat bones which
had been pre-labeled in vivo with

45

ca.

These investigators found that

the addition of calcitonin to the culture medium decreased the release
of

45

ca from the bone; when both parathyroid hormone and calcitonin

were added to the medium the effect was more pronounced.

•

Histological

examination showed that calcitonin diminished the fibroblastic and osteoelastic proliferation stimulated by parathyroid hormone.

A similar, but

less marked, change was observed in the culture to which parathyroid
hormone was not added.

Aliapoulios et al. (1966) demonstrated an

inhibition of resorption in calvariae from 5-day old mice when calcitonin
was added to the incubation medium.
inhibitor of parathyroid hormone.
changes in the

osteocyte~

Calcitonin does not act as an

Reynolds et al. (1967) found that the

and osteoblasts brought about by parathyroid

hormone or vitamin A could not be prevented by calcitonin, but calcitonin would inhibit the increase in osteoclasts.
~,
~:

No changes were ob-

served in hydroxyproline and hexosamine levels of mouse calvariae

h
l-w-h_e_n_c_al_c_i_t_o_n-in_w_a_s_a_d_d_e_d_t_o_t_h_e_c_ul-tu_r_e_m_e_d_i_um
__· __I_n_p_a_r_a_t_h_y_r_o_i_d_e_c_to_-_ _
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roized rats, Foster et al. {1966) noted a drop is osteoblasts after prolonged treatment with calcitonin.
The evidence for an effect of calcitonin on bone formation is unclear and contradictory.

Raisz et al. (1967) observed no increase in

the deposition of calcium from the medium into bone when calcitonin
was added to the incubation medium of embryonic cultures of radii and
ulnae.

Gaillard (1967} observed an increase in osteoblasts in cultures

treated with calcitonin, and Gaillard and Thesingh (1967) observed a
net increase in the length and width of in vitro cultivated radius rudi-

•

ments from 15-day old mouse embryos :when calcitonin was added to
the cultivating medium.

These investigators also cultivated frontal

bone from 18-day old chick embryos together with thyroid tissue of 8day old chick embryos and observed an increase in the growth of the
>;-:

· cultured bones.

These observations indicate that the thyroid tissue of

an 8-day old empryo releases some factor (probably calcitonin) that induces an increase in the width of bone as compared to controls.

In

contrast to Gaillard's results, Baylink, Morey and Rich {1969) using
histological methods concluded that calcitonin decreases both the formation and resorption of bone.

Goldhaber et al. (1968) reached the same

conclusion from investigations which showed that calcitonin reduces the
incorporation of tritiated proline into bone in culture systems.
'

.

<.;

Nisbet

•-.

- 13 and Nordin (1967), on the other hand, found that calcitonin did not
change the uptake of proline-C-14 suggesting that bone formation is not
affected.
Studies on the metabolism of bone are of very little help in
establishing whether bone formation is affected by calcitonin.
et al.
-

Bexter

(1968) reported that calcitonin increased the in vitro synthesis of

----

glucosaminoglycan, indicating an increase in bone formation.

Johnston

and Deiss (1966} incubating calvarfae from young adult rats showed that
calcitonin decreased glucose utilization and lactate production.

In-

•
soluble ·hydroxyproline was also decreased; hexosamine was reduced but
not significantly.

Klein and Talmage (1967) demonstrated that calcitonin

reduces the serum hydroxyproline and the wash hydroxyproline of
peritaneal lavage.

Martin, Robinson and Macintyre (1966) and Aer (1968}

found that calcitonin reduces urinary hydroxyproline excretion.
The increase in citric acid following the administration of parathyroid hormone has been well documented.

Nisbet and Nordin (1967)

in an in vitro system in which cal variae were incubated, studied the
relation between calcitonin and citric acid.

They found that less citric

acid accumulated in the medium when pa;r-athyroid hormone and calcitonin
were added to the cultures than when parathyroid hormone alone was
added.

The differences observed in the incubation medium were not

- 14 -

reflected in the calvariae themselves.
The mode of action of calcitonin on bone is unknown.

It does not

act by inhibiting parathyroid hormone, since it acts in the absence of
the parathyroid glands; it does not have any effect on ribonucleic acid
(Gudmundsson et al. 1966; Tashjian, 1965).

The hypothesis that it may

increase the rate of the de novo synthesis of some enzyme does not have
any experimental support.
Four possibilities have been considered which need not be
exclusive of each other.

First, the hormone both in vitro and in vivo

.

has been shown to reduce the number of' osteoblasts (Friedman and
Raisz, 1965; Reynolds et al. 1967; Matrajt et al. 1967).

Such changes

in the cellular makeup of bone could account for the hypocalcemic
effect of the hormone.

No data is available on the time such changes

occur after hormone administration; the studies available have been
done after the animals had been chronically treated with calcitonin or
after bone cultures had been incubated for days in a medium containing
calcitonin.

The hypocalcemic effect, however. is manifest 15 minutes

after the hormone is administered.

It is not known whether the cellular

changes occur within such short a period of time or whether more
subtle functional shifts occur at the molecular level · and precede the
f.'·
~-

morphological changes.

- 15 A second hypothesis has been advanced by Wells and Lloyd (1968b)
who found that imidazole produces a drop in blood calcium and antagonizes the hypercalcemic effect of parathyroid extract (Wells and Lloyd,
1968).

Imidazole activates adenosine 3', 5'-phosphodiasterase, the
Previous!~

enzyme which degrades cyclic 3'. 5' -adenosine monophosphate.
Wells and Lloyd (1967) showed that theophylline, which inhibits
adenosine 3'. 5' -phosphodiasterase. produced hypercalcemia.

Chase and

Aurbach (1967, 1968) ·showed that p·arathyroid hormone stimulates the
urinary excretion of cyclic adenylate which is dependent upon a direct

..

action of the hormone on the kidneys.

Wells and Lloyd (1968b) pro-

posed that the level of cyclic AMP in bone cells mediates the rate of
calcium mobilization and, secondarily, the level of serum calcium.
Elevations of cyclic AMP level brought about by parathyroid hormone,
theophylline or other drugs. increase the mobilization of calcium; a
decrease in cyclic AMP. brought about by calcitonin, or imi:dazole,
would decrease calcium mobilization.

Substantiation of the hypothesis

proposed by Wells and Lloyd can be found in the work of Chase and
Aurbach (1968).

These investigators have reported that parathyroid

hormone increases adenyl cyclase activity in bone 3 to 5 fold;
calcitonin, however, does not seem to affect cyclase activity.
A third hypothesis involves the regulation of pH at the cellular

- 16 level.

It has long been known that parathyroid hormone increases acid

production.

Recently Nisbet and Nordin (1967) observed that citric acid

levels are reduced in bone culture media when calcitonin is present,
and the reduction is more marked when resorption is stimulated by
parathyroid hormone.

Calcitonin may increase the pH at the cellular

level and decrease calcium mobilization.
Finally. Doty, Schofield and Robinson (1968) observed that acid
.

phosphatase and ATPase are affected by calcitonin and parathyroid hormone in an opposite manner.

Parat11,yroid extract increased the acid

phosphatase of metaphyseal bone

an~

the ATPase of osteoclasts, whereas

calcitonin decreased the levels of these enzymes.

These enzymes may

be involved in the mechanism of action of calcitonin; acid phosphatase
has been implicated as an important factor in the calc:ification process
'·.

i.

(Cartier, 1951).

How these enzymes are related to bone formation and

resorption: is unknown.
Alip.poulios et al. (1966) have shown that extracts of human thyroid
glands contain hypocalcemic activity and Barrett et al. (1968) has purified human calcitonin and found that it was stable and soluble at neutral
pH, whereas porcine calcitonin is not.

In man calcitonin-like activity

has been detected also in the thymus and parathyroid glands (Macintyre,
1968).

Abnormal calcitonin states are suspected to be involved in

- 17 carcinoma of the thyroid gland, pseudoparathyroidism and
hyperparathyroidism.

Increased calcium-lowering activity in either

blood or tumor tissue or both have been fpund.

Removal of the tumor

results in decreased levels of circulating calcium lowering activity
(Milhaud et al. 1968; Cunliffe et al. 1968; Melvin and Tashjian, 1968).
The hypocalcemia associated with pseudohypoparathyroidism is believed
to be caused by excessive secretion of calcitonin.

Aliapoulios et al. ·

(1966) and Tashjian et al. (1966) have shown that thyroid tissue from
patients with pseudoparathyroidism contains approximately 100 times

-

more calcitonin-like activity than normat thyroid tissue.

Tetany and

diffuse non-toxic goiter was found to be associated with increased
calcitonin levels and thyroidectomy resulted in disappearance of the
syndrome (Mazzuoli et al. 1966).
The therapeutic uses of calcitonin have not yet been explored in
great detail.
ap~lication

A serious hindrance to studies on the possible clinical

of calcitonin is the fact that normal man responds poorly to

porcine calcitonin, at the present the main source of the hormone
{Foster et al. 1967; Milhaud et al. 1965; Bell et al. 1966).

Calcitonin

elicits a weak hypocalcemic response in .osteoporotic patients {Foster
et al. 1968).

In a patient with Paget's disease the administration of

calcitonin was found to relieve the pain {Bijvoet and Jansen, 1964).

- 18 The secretion of calcitonin in response to hypercalcemic states
has been well documented (Talmage et al. 1965; Toverod et al. 1966;
Hirsch and Munson, 1966).

In fact it was the result of perfusion studies
..

with hypercalcemic blood that led Copp to postulate the presence of a
..

hypocalcemic factor (Copp et al. 1962).

There has been some question

as to whether the hormone is secreted continuously or only in response
to hypercalcemia.

Talmage et al. (1965) postulated that calcitonin

secretion occurred at .normal plasma calcium levels.

It has now been

demonstrated that secretion of calcitonin occurs at normal and sub.normal calcium levels (Deftos, Lee and Potts, 1968).

It has also been

established that the plasma calcium controls the levels of circulating

V

calcitonin (Care et al. 19 69).

STATEMENT OF THE PROBLEM
A study of the in vitro biosynthesis of calcitonin would be of value
in attempting to define those conditions which in the organism control
the synthesis and release of the hormone.

There have been a number

of studies of the in vitro· biosynthesis of polypeptide hormones. · ·Bauer
and Lazarow (1961) and Mallory et al. (1964) have reported the incorporation of radioactive amino acids into insulin using goosefish islet

~-·

- 19 and rat pancreas, respectively.

More re.cently Steiner and Oyer

and Steiner et al. (1967) using rat pancreas and islet cell tumor
demonstrated the incorporation of labeled amino acids into insulin
and a precursor molecule.

Takabatake and Sachs (1964) reported the in

-vitro biosynthesis of vasopressin by hypothalamic tissue.

Wool et al.

(1961) and Adiga et al. (1965) using various labeled amino acids demonstrated the in vitro biosynthesis of ACTH in anterior pituitary tissue.
Wakabayashi and Tamaoki (1967) have reported the synthesis of LH by
isolated anterior pituitary glands and have studied the effect of androgens

.

the synthesis.

By using the general experimental approach used for the biosynthesis of these polypeptide hormones we propose to synthesize calcitonin in an ovine thyroid slice system.
the tracer amino acid.

Glycine-C-14 will be used as

Calcitonin titers in the blood are thought to be

controlled by the levels of calcium; high levels of calcium inducing an
increase and low levels inducing a decrease in the circulating calcitonin.
'.

,:.'.

In perfusion studies of the thyroid glands (Care et al. 1968; Lee et al.
1969) it has been shown that in vivo an increase in the calcium concentration of the perfusing medium resulted in increased circulating hypocalcemic activity.
Since. in vivo
r~ ·.

~he

increased hypocalcemic activity. obtained in the
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high calcimn perfusion studies, may have been the result of synthesis,
or both, we will study the effect of calcium on the synthesis
effect of calcium on the release of the hormone in the in vitro
synthesizing system to establish the role of these ions on calcitonin
biosynthesis and release.

Since it has been reported that magnesium

affects the synthesis of parathyroid hormone (Buckle and Care, 1967),
we will also study the effect of magnesium on the synthesis of calcitonin
in the ovine thyroid slices.

~

t

.

~.

::.'
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MATERIALS AND METHODS
GENERAL EXPERIMENTAL PROCEDURE
In the first part of this work our main purpose was to develop
a system for the incorporation of glycine-C-14 into proteins. of ovine
thyroid slices, and more specifically the isolation, from the slices of
calcitonin containing a radioactive amino acid.

For this purpose ovine

thyroid glands were obtained from the slaughterhouse as soon as

..

possible after the animal was killed - - 1,J.Sually 10-20 minutes.
glands were placed in cold Krebs-Ringer bicarbonate buffer

* (pH

The
7. 4)

and were brought to the laboratory where they were dissected free from
fat. connective tissue. and other adhering structures, then washed with
cold Krebs-Ringer bicarbonate buffer (pH 7. 4) and cut with a StadieRiggs plastic tissue slicer into slices approximately O. 5 - 1. O mm in
thickness.

The slices were then transferred into a series of 50 ml

Erlenmeyer flasks (approximately 2. O gm of slices per flask) containing
10 ml of Krebs-Ringer bicarbonate buffer (pH 7. 4) to which was added

~~

.·

The phrase "Krebs-Ringer bicarbonate buffer" whenever used later in
this dissertation means a Krebs-Ringer bicarbonate buffer to which was
added glucose (320 mg/ 100 ml) and all the amino acids of calcitonin
(20 mg/liter) with the exception of the one used as a tracer.

- 22 glucose (320 mg/ 100 ml) and all the amino acids of calcitonin (20 mg/
liter) but the tracer.

To each flask 2. 5 µCi of the tracer amino acid

The incubation was carried out at pH 7. 4 in a constant
shaker water bath at 37

0

C for 4 hours.

Flasks which contained, in

addition to the above, 1. O ml of 50% trichloroacetic acid served as
controls.

The incubation of the experimental flasks was terminated by

addition of 1. 0 ml of trichloroacetic acid to each flask.
The tissue slices after incubation were cut into small pieces with
scissors and washed 10 times with cold acetone, 6 times with cold

•

chloroform and again 10 times with cold' acetone.

The defatted tissue

was then driec;l at room temperature and stored at 4° C until it was
used.
The defatted tissue was then extracted with 10 volumes of 8. O M
urea - 0.1 N cysteine in O. 2 N HCl for one hour at room temperature.
The mixture was then squeezed through. cheese cloth and washed with a
volume of doubly-distilled water equal to that of the extraction solution.
The filtrate and washings were combined and dialyzed against O. 1 M
acetate buffer (pH 4. 6) for 24 hours at 4

0

C.

To the dialysate was

then added 3. O M NaCl to a final concentration of 1. O M.

After stand-

ing for 72 hours at 4° C the precipitate was collected by centrifugation
at 4

0

C at 1400 RCF for 3 hours.

The inactive precipitate was dis-
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and to the supernatant was added solid NaCl to a final concenof 2. O M.

After 72 hours at 4° C the active precipitate was

collected by centrifugation at 4

0

.

.

C at 1400 RCF for 3 hours.

precipitate was then dried by lyophilization.

The

The dried material was

then purified on Sephadex columns.
Radioactivity and biological activity were measured at each step
during the isqlation.

Biological activity was estimated by the hypo-

calcemic response to the injection of the test material in rats.

Radio-

~' :

activity was measured by liquid scintillation
counting (Beckman LS
,,.
250 Liquid Scintillation Spectrometer) ana total protein was determined
by a modification of the Lowry method.
Once we were able to show that calcitonin is synthesized in vitro
we studied the effect of high concentrations of calcium on the synthesis
and the release of the hormone.

The effect of high concentrations of

magnesium on the synthesis of calcitonin was also studied.

In this

part of our investigation, the slices were incubated in normal, high
calcium, or high magnesium media.

To assess the extent of synthesis

the slices were extracted and calcitonin isolated through the second
sodiun;l chloride precipitation step.

The lyophilized material was dis-

solved in O. 1 M acetic acid and injected intravenously into rats.

The

fall in serum calcium at 50 minutes was taken as the index of hypo-

- 24 calcemic activity.

The difference between the hypocalcemic activity of

glands incubated in normal and high calcium or high magnesium was
taken as representing the extent of synthesis.

To measure the amount

of released hormone at the end of the incubation the slices were removed and the media was injected into rats for bioassay; the. fall in
serum calcium 50 minutes after the administration of the calcitonin
preparation was taken as the index of hypocalcemic activity released into
the medium.

..
":r.

CHEMICALS
Acetic Acid, Glacial, J. T. Baker Chemical Company, No. 9507.
Acetone, Mallinckrodt Chemical Works, AR No. 2440.
Amino Acids, L form, · Mann Research Laboratories, Inc. , (M.A.)
Kit 00100-721.
Albumin, Crystalline, Pentex, Inc., Lot No. 16.
Blue Dextran 2000, Pharmacia Fine Chemicals, Inc., No. 4474.
Calcein Indicator. Fisher Scientific Company, No. C-566.
Calcium Carbonate, Mallinckrodt Chemical Works, AR No. 4071.
Calcium Chloride • 2 H 0, Mallinckrodt Chemical Works, AR No. 4160.
2
Chloroform, Mallinckrodt Chemical Works, AR No. 4440.
Copper Suliate • 5 H 0, Mallinckrodt Chemical Works, AR No. 4844.
2
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L-(+)-Cysteine Hydrochloride, Eastman Organic Chemicals, No. 2367.
Dextrose. Anhydrous, Mallinckrodt Chemical Works. AR No. 4912.
p-Dioxane. (stabilized), Mallinckrodt Chemical Works, AR No. 4937.
Disodium Ethylenediamine Tetracetate, Versenes, Inc.
Folin-Ciocalteu Phenol Reagent, Harleco.
Formic Acid 88%, Mallinckrodt Chemical Works. AR No. 2592.
14
c-Glycine (UL), Nuclear-Chicago, Batch No. 14, S. A. 108 mc/mM.
Tracerlab, Lot No. 78-81-2, S •. A. 70 mc/mM.
-~

Hydrochloric Acid, J. T. Baker Chemical Company, No. 9535.

,,
Magnesium Sulfate · 7 H 0,
2

Mallinckrod~

Chemical Works, AR No. 6056.

Naphthalene, Matheson, Coleman and Bell, NX5.
Pentobarbital Sodium, Abbott Laboratories, No. 3117.
Potassium Phosphate Monobasic, Mallinckrodt Chemical Works, AR No.

Potassium Sodium Tartrate, Mallinckrodt Chemical Works, AR No. 2367.
Sephaciex G_::.._f_O_Q, Pharmacia Fine Chemicals, Inc., No. 6164.
Sephadex G-50, Superfine, Pharmacia Fine Chemicals, Inc., No. 5739.
Sodium Acetate, Anhydrous, J. T. Baker Chemical ·company, No .. 3742.
Sodium Bicarbonate, Mallinckrodt Chemical Works, AR No. 1412.
Sodium Chloride, Mallinckrodt Chemical Works, AR No. 7581.
Sodium Cyanide, J. T. Baker Chemical Company, No. 1144.
Sodium Hydroxide, Mallinckrodt Chemical Works, AR No. 7708.

- 26 Trichloroacetic Acid, Mallinckrodt Chemical Works, AR No. 2928.
Mallinckrodt Chemical Works, AR No. 8648.

PREPARATION OF INCUBATION MEDIA
Krebs-Ringer bicarbonate buffer or a modification thereof served
.J

as the medium for the incubation.

.

.

Normal composition of the Krebs-

Ringer bicarbonate buffer is as follows:

100 part (s)

'
~~"
e;·
ti·
1'

••

o. 90%

(0. 154 M)
rr

..

NaCl solution

4

"

1.15

3

"

1.22

(0. 110 M)

CaC1

1

II

2. 11

(0. 154 M)

KH2 S0
4

1

II

3.82

II

21

"

1.30

"

*Final concentration
\

KCl

.,,,
....

"
II

{0.0025 M)*

"

(0.0012 M)*

.

4

NaHC0

.,,,
....

(0. 0047 M)

2

MgS0

(0. 118 M)

3

7H 0
(0. 0012 M)
2
solution

"

Ionic strength· =

=
(Mg++ =

*

(0.0248 M) *

q. 1600

11. 51 mg/100 ml)
3. 7 mg/ 100 ml)

Twenty milligrams of each of the amino acids of calcitonin (with
the exception of the tracer) and 3. 2 grams of glucose were added to
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each liter of buffer.

An oxygen-carbon dioxide (95%:5%) mixture was

bubbled into the medium for fifteen ininutes and the pH was adjusted to
7. 4 before it was used for incubation.
Modifications of the above mentioned Krebs-Ringer bicarbonate
buffer were prepared to serve as high calcium and high magnesium
.·

media by increasing the calcium and magnesium ion concentration in
such a way that calcium. ion plus magnesium ion concentration were
approximately equal.

The final compositions of the modified buffer

solution were as follows:

•

High-calcium medium
100 part (s)

o. 90%

(0. 154 M)

NaCl solution

(0. 0101 M) *

II

12

"

1.22

(0.110 M)

CaC1

4

II

1. 15

(0. 154 M)

KCl

1

"

2.11

"

KH2 SO 4 ''

1

II

3.82

"

MgSO 4 • 7 H20

II

NaHC0

21

"

1. 30

:.:~

Final . concentration

(0. 1180 .M) *

2

(0.0047 M) *

"

(0. 0012 M)

solution
II

Ionic strength
=

(Mg++

=

(0. 0012 M)*

(0. 0248 M)

3

=

*
i,c

O. 1838

45. 6 mg/ 100 ml)
3. 7 mg/ 100 ml)

i.

1----------~
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100 part (s)

....

o. 90%

(0. 154 M)

NaCl solution

II

1.22

(0.110 M)

C~Cl

4

"

1.15

{O. 154 M)

KCl

1

If

Z.11

II

KH P0 II
2
4

8

II

3.82

II

MgS0

II

1.30

*Final concentration

II

4

(0. 0047 M)

*

..,.
{0.0012.M)"'

• 7H 0
*
2
{O. 0089 M)
solution
II

{O. 154 M)

Ionic strength

(Mg++

M>"'

....
(0.0025 M)"'

II

·3

2

(0.1180

(0. 0248 M)

=

*

0. 1838

=

11. 51 mg%)

=

29.78 mg%)

'·

TISSUE PREPARATION AND INCUBATION
OVine thyroid glands were obtained from the slaughterhouse
(Chicago Lamb Packing Company, 3907 Halsted Street, Chicago, IDinois)
between nine and ten o'clock in the morning and usually 10-20 minutes
after sacrifice the glands with all adhering tissues were placed in cold
Krebs-Ringer bicarbonate buffer (pH 7. 4) and brought to the laboratory
where they were dissected free from fat, connective and other adhering
tissue and sliced in the cold into slices approximately O. 5 - 1. O mm in
thickness with a Stadie-Riggs tissue slicer.

The elapsed time between

- 29 ·sacrifice and incubation was usually four hours.

The slices were

weighed and about two grams were placed in each of a series of 50 ml
Erlenmeyer flasks.

Each flask contained 10 ml of Krebs-Ringer bi-

carbonate buffer and 2. 5 p.Ci of the labeled glycine.

Some flasks con-

in addition to the above, 1. O ml of 50% trichloroacetic acid and
as controls.

The gas phase for all incubations was air, and

incubations were carried out in a hood.
All incubations were carried out in a temperature controlled
shaker water bath at 37

0

C for 4 hours .

•

Incubations were terminated by the ·addition to the flasks of 1. O ml
50% TCA or by placing the slices into cold acetone.
To determine the effect of high calcium and high magnesium ions
on synthesis and release of hormones, the incubations were carried out
in buffer containing normal (11. 4 mg Ca++/ 100 ml; 3. 7 mg Mg++/ 100
ml), high calcium (45. 6 mg Ca++

I 100 ml; 3. 7 mg Mg++ I 100 ml) and

high magnesium (4.51 mg Ca++ /100 ml; 29.78 mg Mg++ /100ml) concentrations.

After incubation, aliquots of the high calcium medium were

assayed for calcitonin activity to determine the release of the hormone
from the slices.

The slices were extracted for calcitonin through the

second sodium. chloride fractionation step.

The material obtained was

lyophilized", dissolved in O. 1 M acetic acid buffer (pH 4. 6) and assayed

- 30 -

for hypocalcemic activity.

EXTRACTION, ISOLATION AND PURIFICATION OF CALCITONIN
When the incubations were terminated, the slices were minced with
scissors and washed ten times with cold acetone, six times with cold
chloroform and again ten times with cold acetone.

The resulting lipid-

free tissue was dried at room temperature (Rasmussen, 1959) and
stored in a desiccator, unless immediately used.

The acetone dried

material was weighed and extracted with ten volumes of 8 M urea - 0. 1
N. cysteine in

_o. 2

N HCl (Rasmussen,.· 1964).

The isolation and purifi-

cation of the extract follows the pr9cedure of Gudmundsson, Macintyre

•.

Ji:

..
·

and Soliman (1966).

The mixture was stirred and allowed to stand for

one hour at room temperature.

It was then filtered through cheese

cloth and the residue washed with doubly distilled water (10 ml/gm dry
powder).

The washings were combined with the filtrate and were

. dialyzed against O. 1 M sodium acetate buffer (pH 4. 6) for 24 hours at
4° C.

['he dialyzate was made up to 1. 0 M with respect to sodium

chloride with 3. 0 M NaCl and allowed to stand at 4° C.

After 72 hours

the precipitate (inactive) was removed by centrifugation (1400 R. C. F.)
'
.
for 3 hours
at
4 0 C.

Solid sodium chloride was added to the super-

natant to a final concentration of 2. 0 M.

After standing for a further 72
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at 4° C the precipitate was collected by centrifugation (1400
for 3 hours at 4

0

C.

The precipitate was dried by lyophiliza-

The dried precipitate was dissolved in O. 1 M forrnic acid (18 mg/
and applied to a 2. 5 x 45 cm column of Sephadex G-100 and eluted
with the same solvent.

The transmission of the effluent at 280 mµ was

monitored with a Uvicor?- Absorptiometer and Recorder (LKB Instruments,
Inc., Rockville, Maryland) and fractions were collected on a Gilson
Fraction Collector

v

15

{Gilson Medical Electronics, Middleton,
,,.

Every fourth fraction was assayed for hypocalcemic
When one fraction containing hypocalcemic activity was found,
the fractions preceding and following that fraction were assayed for
hypocalcemic activity until one fraction on either side was found not to
,

contain biological activity.

The fractions containing hypocalcemic

activity -were pooled, lyophilized and stored at 4° C until used.

The

dried material was dissolved in 1. O M formic acid and applied to a
\

O. 9 x 45 cm column of Sephadex G-50 superfine and eluted with a
solution of 0 .. 1 M formic acid - 1. O M urea - O. 2 M sodium chloride.
For biological activity the dried material was appropriately dissolved in
O. 1 M acetic acid and assayed.

The fractions from the Sephadex G-50

column were scanned for hypocalcemic activity (vide supra); the
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containing hypocalcemic activity were pooled, lyophilized and
biological activity determined.

A diagram of the fractionation and

·.. purification procedure is shown in Figure 2.
To assess the purity of the fractions containing hypocalcemic
an aliquot from each fraction was chromatographed on thin
layer cellulose sheets {Eastman Chromatogram Sheet 6065, cellulose
with fluorescein indicator).

For chromatography 50 µl of each fraction

was applied to a sheet and developed with the upper phase of a butanol:
acetic acid: water (4:1:5} system for 2. 5 hours.
were also chromatographed.
"

The combined fractions

"

Two dimensional chromatography was done

on the combined fractions on cellulose thin layer sheets.

2 5 µl of the

combined fractions. were applied on one corner of the sheet and
developed in one direction with a butanol: acetic acid: water system and
in the other direction with a propanol: water {70:30 v/v) system.
(,

~.·.

'

The

migration of the sample applied was determined with a UV lamp.

~<~

~·

To characterize further the biological active peptide 100 µl (4 µg
protein) of the combined fractions containing hypocalcemic activity from
the Sephadex G-50 column were subjected to hydrolysis with 6. O N
HCl for 24 hours at 110

0

C.

The hydrolyzate was evaporated to dry-

ness, redissolved in water and again evaporated to dryness; the dry
material w·as dissolved in O. 01 N HCl and analyzed for amino acids on
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MINCED THYROID SLICES
Extraction
(10 x with cold acetone
6 x with cold chloroform
10 x with cold acetone}

RESIDUE (dry at room temperature)
Extraction
10 volumes 8. 0 M urea - O. 1 N
cysteine - O. 2 ,N HCl
1 hour at room temperature
Filter through cheese cloth

RESIDUE

FILTRATE

wash with 10
volumes water
WASHINGS _ _ _ _ _ _ _ _ _ _ _....,..__ ___

+

Dialyze against
O. 1 N acetate buffer (pH 4. 6)
0
24 hours 4 C

Residue

DIALYSATE
Add 3. O M NaCl
to make a 1. O M
Allow to stand 72 hr 4° C
Centrifuge 3 hr 1400 RCF
,•·

Precipitate
(Inactive}

SUPERNAT~NT

-

Figure 2. · Flow Diagram for Fractionation and Purification of Calcitonin
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!_igure 2, continued

~jprec1p1
r ·tat e

I

SUPERNATANT

; (Inactive)

Add solid NaCl to make 2. O M
Allow to stand 72 hr 4o C
Centrifuge 3 hr 1400 RCF

PRECIPITATE
(active)

Supernatant

Lyophilize
Dissolve in O. 1 M formic acid
Apply to Sephadex G-100
Elute with 0. 1 M formic acid ..
ACT! E FRACTIONS
Lyophilize. Dissolve in 1. O M formic acid
Apply to Sephadex G-50 superfine column.
Elute with 0.1 M formic acid - 1. O M urea O. 2 N HCl

ACTIVE FRACTIONS
Thin layer chromatography
Amino acid analysis
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Amino Acid Auto analyzer.

DETERMINATION OF SERUM CALCIUM
A method for determining ionizable calcium in serum by Ashby
Roberts was modified for use in this work.
obtained from rats by tail bleeding.

Blood samples were

The tail was placed in warm

water for about one minute, a quarter of one-half inch of the tail was
cut with a sharp blade and the blood collected.

The blood was placed

in the refrigerator for about one hour before the clot was separated

from the serum by centrifugation for two minutes in a Beckman Spinco
Microfuge.

Thirty microliter aliquots of serum were added to micro-

titrator cups; to each cup were added 150 microliters of 0. 002 M

EDTA, one drop (about 60 microliters) of properly diluted calcein
indicator~ one drop of 1% sodium cyanide solution,

"·

N sodium hydroxide.

and one drop of 1. 0

Titrations were performed with a Beckman

Spinco Microtitrator filled with a 20. O mg% standard calcium solution.
A long wave ultraviolet lamp (Mineralight, Model SL 3660) was placed
about 2 inches above the titration cup.

The standard calcium solution

was added with continuous stirring until a green fluorescence appeared.
The calcium concentration of the sample is directly proportional to the
difference in mforoliters of standard calcium solution required to

- 36 the sample and to titrate a water blank.

A 12. O mg% standard

solution was titrated with each group of samples, and the calcium concentrations were calculated as follows:

mg% calcium = 12. 0 mg%

x

microliters for unknown
microliters for 12. 0 mg% standard

microliters for unknown

microliters of titrant required to titrate

=

blank minus microliters of titrant required

.

to titrate unknown sample

microliters for 12. 0 mg%
standard

=

microliters of titrant required to titrate
blank minus microliters of titrant
required to titrate 12. 0 mg% standard

Figure 3 indicates the linear relationship between the microliters
of titrant used and the concentration of calcium and the data for this
standard curve appears in Table I.
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TABLE I

Standard Curve Data for Calcium Determination

Calcium
mg%

No. of
Samples

Microliters
of Titrant

Microliters
(Titrant - 0 mg%)

0 Blank

~

+
29.31 - 0.13

-----

4

6

+
23.62 - 0.26

5.69

6

5

+
20.29 - 0.13

9.02

8

6

17.66 - 0.19

10

6

14.69

- o. 08

14.62

12

6

+
11. 59 - 0.13

17.72

14

4

+
8.77 - 0.15

20.54

16

5

+
5.67 - 0.13

23.64

"

+

+

11.65

~.·
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solutions
Calcein solution-concentrated:

O. 25 gm of powdered indicator was

dissolved in 40 ml of 1. O N NaOH.

The solution was diluted to 1000 ml

with doubly distilled H 0.
2
Calcein Indicator solution:

0. 5 ml of the concentrated calcein solution

was diluted to 2 5 ml with doubly distilled water.
Calcium standard solution (20 mg%):

O. 2497 gm of oven dried calcium

. carbonate was dissolved in 30 ml of 2 N HCl and diluted to 500 ml with
doubly distilled water.

Working solutions were prepared from this

•

stock solution.
Ethylenediaminotetraacetic acid:

187. 5 mg of Na EDTA was dissolved

2

in C0 -free H 0 to a total volume of 500 ml.
2
2

PROTEIN ANALYSIS
Protein was determined according to the method of Lowry (1951)
as modified by Oyama and Eagle (1956).

One milliliter of reagent "C"

was placed in each of 9 x 75 mm test tube.

To each tube was added

200 µl of sample {water for the blanks), the contents were mixed and

alloweP, to stand for 10 minutes.

Then

q. 1

agent was added to each tube with mixing.

ml of Folin-Ciocalteu reThe tubes were allowed to

stand for 30 minutes and the transmittance read at 750 mµ on a
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DU spectrophotometer.

A standard curve was prepared

the same procedure using bovine serum albumin as standard.
for the calibration curve are giv.e.n in Table II and the
standard curve appears in Figure 4.

The transmittance is converted to optical density and the density
of the reagent blank is subtracted from that of the experimental and
standard tubes.

The concentration of the unknown is calculated using

the formula:

OD

u
X

OD

(concentration of standard)

s

X

5

=

protein/ml of unknown
sample

"·

Solutions

I·

Reagent A:

20 gm of Na

KNaC H~0

· 4H 0 were dissolved in one liter of doubly distilled water.
2

4

~eagent

6

B:

2

co 3 •

5 gm of CuSO

4

4 gm of NaOH and 200 mg of

· 5 H 0 were dissolved in one liter of
2

doubly distilled water.
Folin-Ciocalteu Reagent:

Folin-Ciocalteu Reagent was obtained

commercially from Fisher Scientific Company and diluted with doubly
distilled H 0.
2

The dilution (usually 5:7) giving the highest optical
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TABLE II .

Standard Curve Data for Protein Determination

Albumin {µg)

No. of
Determinations

OD750

5

6

0.0873

10

6

0.1634

20

6

0.1634

30

5

0.4036

40

6

0.5393

50

5

0.6025

r---------------~
~·-
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FIGURE 4.

STANDARD CURVE FOR PROTEIN DETERMINATION
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density that was stable for two hours was selected.
I

Reagent C:

Fifty parts of reagent A and one part of reagent B were

mixed fresh on the day of use.

Measurement of Radioactivity
A Beckman LS-250 Liquid Scintillation Spectrometer was used for

all the radioactivity determinations.

Samples were counted in twenty-

two milliliter low potassium-40 content glass vials with tin-foil lined
plastic screw caps.

Ten milliliters of the desired scintillation fluid

were placed in each vial.

To the sc!i.ntillation fluid was added an

appropriate amount of the sample and the sample was counted five times
for five minutes each time.
The scintillation fluid was prepared by dissolving 4. 0 gm of PP 0
and 100. O gm of naphthalene in p-dioxane and made up to the volume of
one liter.

DETERMINATION OF BIOLOGICAL ACTIVITY
Male Holtzman rats weighing from 100 to 110 _grams (Holtzman
Company. Madison. Wisconsin) were kept in the laboratory and fed

.
standard rat chow until they reached a weight of 140 to 170 grams at
which time they were used for determination of biological activity of
calcitonin preparations.

- 44 The animals were anesthetized with sodium pentobarbital injected
intraperitoneally at a dose of 5 mg per 100 grams of body weight.

A

blood sample was collected from the tail. .. The animal was placed on an
operating board, an incision was made along the thigh to expose the
femoral vein.

250 µl of calcitonin preparation, or vehicle, was injected

into the vein using a Hamilton syringe of appropriate size, except for
the experime!:!tS to determine the effect of calcium on calcitonin release
from the thyroid slices when 150 µl of incubation medium or buffer was
injected into the vein.

The incision 11as then closed with wound clips.

After fifty minutes, while the animal was still under anesthesia, another
blood sample was collected.
The blood was allowed to remain in the refrigerator for about
one hour for .clot formation.
separate the serum.

It was then centrifuged for two minutes to

The serum was analyzed for calcium and the

difference between the calcium at zero time and fifty minutes was used
as an index of the effect of the material administered.
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CHAPTER ill
EXPERIMENTAL RESULTS
The experimental portion of this work comprises two parts.

These

include the biosynthesis and purification of calcitonin, and the bioassay
of the synthesized material.

In the biosynthesis and purification studies,

a system for the incorporation of glycine-C-14 into ovine thyroid slices
was developed..

The slices were then subjected to isolation and purifica-

tion procedures to obtairi a highly purified calcitonin preparation.

The

medium used for the incubation was krebs -Ringer bicarbonate buffer,
pH 7. 4, to which was added glucose and the amino acids of calcitonin
to stimulate protein synthesis and calcitonin synthesis in particular.
The second part of this work comprised the study of the effects of
high calcium and high magnesium concentrations on the synthesis and
release of calcitonin from the thyroid slices.

This was done in an

attempt to define the conditions which control the synthesis and release
of the hormone.

The Effect of the Addition of Glucose and Amino Acids of Calcitonin to
the Incubation Medium on the Incorporation of Glycine-C-14 in Thyroid
Proteins.
One gram of ovine thyroid slices was incubated with 1. 25 p.c of

r

r-
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glycine-C-14 (UL) in 25 ml Erlenmeyer flasks containing 5. O ml of
buffer.

The incubations were carried out at 37

constant temperature shaking water bath..

0

C for 4 hours in a

The gas phase was air.

The

incubations were terminated with the addition of one milliliter of 50%
trichloroacetic acid.

The slices were homogenized in distilled water

and 100 µl of the homogenate was counted in a liquid scintillation mixture containing 6% Cab-0-Sil {Packard Instruments Company, Downers
Grove, Illinois).

The protein in the homogenate was determined and

the radioactivity expressed in disintegrations per minute per milligram

..

protein.
The data on the effect of glucose and the amino acids of calcitonin
are presented in Table ID.

It is readily evident that the radioactivity

represents true incorporation since the slices in the "killed" fl.asks
show negligible radioactivity.

It is also evident that glucose markedly

stimulates the incorporation of glycine-C-14 into the thyroid tissue, the
increase above the basal level is approximately 200%.

The addition of

the calcitonin amino acids alone has no significant effect on the isotope
incorporation.

The addition of both glucose and amino acids increases

incorporation with respect to the basal level (102%).

However, a de-

crease in the incorporation of the radioactive label is observed when
compared to the medium with glucose alone.

TABLE III
Effect of Glucose and Calcitonin Amino Acids on the Incorporation of Glycine-C-14
in the Proteins of Ovine Thyroid Slices

No. of
Incubations

Medium
:>le

DPM/100 mg Tissue

DPM I mg Protein

+

33

----- ----

79527 - 795

10207 - 102

+ 211

8

30484 ::. 30 5

3804 :: 380

7

+
60957 - 610

6623 - 662

84 -

8

30275 - 300

3283 -

Basal + glucose

8

Basal + amino acids
Basal + glucose
+ amino acids

Basal

8

8963 ::

90

Killed

**

% Change

+

+

•

+

8

+

+

+

***

16

+ 102

*Killed

refers to flasks to which 1. O ml of 50% TCA was added to the medium at the start
of incubation.

** Basal

.

refers to those flasks containing only Krebs-Ringer bicarbonate buffer with no additions.

**>~% Change is the change in DPM/mg protein over the basal level.

~
-,)
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In all subsequent incubations we used the medium to which glucose
and the amino acids of calcitonin were added.

We believe that the de-

crease in incorporation observed with this _medium was due to a decrease in the incorporation of label into proteins requiring other amino
acids besides those of calcitonin.

The lack of these amino acids de-

pressed the synthesis of those proteins requiring other amino acids in
addition to those added, whereas the synthesis of those proteins and
polypeptides made up only of the amino acids of calcitonin would be
accelerated.

When glucose alone was added the synthesis of many

•

small peptides would result with very few complete proteins formed,
since the only source of essential amino acids would be the pool of
amino acids present in the slices and from the breakdown of other
proteins.

The Synthesis of Calcitonin in Krebs-Ringer Bicarbonate Buffer Containing Physiological Concentrations of Calcium.
To determine whether calcitonin was being synthesized at physiological concentrations of calcium, ovine thyroid slices were incubated in
Krebs-Ringer bicarbonate buffer containir:ig 11. 5 mg calcium per 100 ml
of buffer.

18 to 20 grams of slices were found necessary to extract an

amount of· calcitonin sufficient for the assay of hypocalcemic activity.

- 49 For this experiment, 20 grams of slices were i!lcubated in KrebsRinger bicarbonate buffer in 2. O gram quantities in 50 ml Erlenmeyer
flasks containing 10 ml of buffer.

The incubations were carried out in

an atmosphere of air at 37° C for 4 hours and were terminated with
the addition of 1. O ml of 50% trichloroacetic acid to each flask.
The incubated glands and 20 grams of unincubated glands were
extracted and calcitonin was isolated through the second sodium
chloride precipitation step.

The active precipitate was lyophilized,

dissolved in O. 1 M acetic acid and the
hypocalcemic activity assayed in
,,.
140-170 gram Holtzman rats.
assay.

The rats' were fasted 18 hours before

Each rat received intravenously 250 µl of the calcitonin

preparation which contained 125 µg of lyophilized material.

The calci-

tonin preparations were analyzed for protein content and the change in
serum calcium was expressed as !:::.. Ca per 10 µg protein.

Comparison

of the decrease in serum calcium (Table IV) obtained with the calcitonin
preparation obtained from incubated and unincubated glands shows that
only a small difference statistically not significant (0. 11 mg% Ca)
exists.

This finding is in accord with in vivo observations which indi-

•

cate that at physiological serum calcium concentration only small
amounts of calcitonin are present in the circulation.

- 50 TABLE IV
fl:vpocalcemic Activity of Calcitonin Preparations Isolated from Unincubated
Ovine Thyroid Glands and from Thyroid Slices Incubated in Krebs-Ringer
Bicarbonate Buffer Containing Physiological Concentrations of Calcium.

UNINCUBATED GLANDS
Ca mg%

"

6.Ca mg%

6.Ca/10 µg
mg%/Protein

Animal
No.

t

i

ii.46

11. 27

- 0.19

l

11.52

10.44

1. 08

1. 23

3

11. 78

11.47

- 0.31

0.36

4

11.44

10.73

- 0.71

- 0.81

s

11.86

11.31

0.56

0.64

t50

0

-

-

+

.~··

0.22

+

Mean - s. e •

0.65 - 0.17

ti"'.

~;

"'
~r

INCUBATED GLANDS

i'

Ca mg%
Animal

6.Ca mg%

6.Ca/10 µg
mg% /Protein

No.

to

t50

i

12.04

11.30

- 0.74

- 0.87

2

11.. 45

11.22

0.23

0.27

3

11.97

11.36

- 0.61

-

0.71

4

12.20

11.54

- 0.66

0.78

5

12. 12 ..

11. 10

-

-

+

Mean - s. e.

1.02

-

1.19

+

0.76 - 0.15

r--------------------51--------------------r
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The Effect of High Calcium Concentrations on the Synthesis of Calcitonin

~:

by Ovine Thyroid Slices.
Since calcitonin titers in the

circulat~on

seem to be controlled by

.....

the serum calcium concentration. and since at physiological concentrations of calcium no net synthesis was observed, it became apparent that
if a significant amount of synthesis was to be observed, the calcium concentration in the incubation media would have to be increased.

Krebs-

Ringer. bicarbonate buffer was prepared such that the calcium ion concentration was. 45. 6 mgs per 100 ml of buffer.

•

To eliminate any variation

which may have existed in the content of calcitonin of the glands due to
the source and age of the animals, food ingested and season of sacrifice.
incubations in buffer containing physiological and high concentrations of
calcium were carried on at the same time.
After incubation the glands were pooled and calcitonin isolated
through the second sodium chloride precipitation step.

The precipitate

was lyophilized. dissolved in O. 1 M acetate buffer and its hypocalcemic
activity assayed in 140-170 gram rats.
When the amount of calcitonin is determined, the preparation obtained .from glands incubated in Krebs-Ringer bicarbonate buffer containing high concentrations of calcium (45. 6 mg%) show higher hypocalcemic
activity than those preparatfons obtained from glands incubated in Krebs-

r;_ _ _ _ _ _
f~.··

---w
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L,

~

Ringer buffer containing physiological concentrations of calcium (11. 5
mgo/o) (Tables V and VI).
· The net effect has in each case been calculated by adding to the
effect of the administered preparation the effect of the vehicle alone
that of O. 1 M acetic acid.

As shown in Table VII, the vehicle alone

raised the serum calcium by an average of O. 55 mg.

The decrease

in serum calcium is greater for the three preparations obtained from

the glands incubated in buffer containing high calcium concentrations
than for those incubated in buffer containing physiological calcium con-

•

centrations.

The fall in serum calcium

i~

4. 9%. 5. 0% and 6. 2% for

the three preparations respectively.
A comparison of the hypocalcemic activity of the calcitonin
preparations obtained from slices incubated in buffer containing physiclogical concentrations of calcium with preparations obtained from glands
incubated in buffer containing high concentrations of calcium shows that
the difference of the means of preparations 2 and 3 is statistically
significant at the 5% level or less, as ·evaluated by a Student's "t"
Test.

The significance of the difference of the means of preparation 1

is questionable and lies between the 10 ar.id 5% level.
These findings support the in vivo studies which show that hypercalcemia increases the circulating calcitonin activity.

~
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v

Hypocalcemic Activit;y of Calcitonin Isolated from Ovine
Th;yroid Slices Incubated in Krebs-Ringer Bicarbonatlr
Buffer Containing Ph;ysiological Calcium Concentrations

Preparation

Animal
No.

1 -

Mean
2

Ca mg%

Net
Change

t5o

1

11.52

11. 04

- 0.45

- 1. 00

8.9

2

12.13

11. 89

- 0.78

6.5

3

11.88

10.82

- 0.23
- 1.00

- 1. 55

13.1

4

12. 13

11.92•

- 0.20

- 0.75

6.3

-

1.02 +- 0.18

8.7

- 1.88
- 1.48
- 1. 28

+- s. e.

-

-

Mean +
- s. e.

%
Change

to

1

9. 97

8.25

- 1.43

2

9.76

8.63

-

3

10.87

9.98

- 0.73

+
Mean - s. e.
3

Ca/10 ~g
mg% /Protein

0.93

20.0
15.2
11.9

- 1.55 +- 0.18

15. 7
11.8

1

12.04

11.30

- 0.87

- 1.43

2

11.45

11.22

- 0.27

-

0.83

7.2

3

11.97

11. 36

- 0.71

- 1.26

10.6

4

12.20

11.54

- 0.78

1.33

11.0

5

12.11

11. 10

- 1. 19

-

1. 74

14.5

- 1.31 +- 0.15

11.0

- 54 TABLE VI
Hypocalcemic Activity of Calcitonin Isolated from Ovine
Thyroid Slices Incubated in Krebs-Ringer Bicarbonate

•,

Preparation . Animal
No.

'.

"

1

-

Ca mg%
to

Ca/10 µg
mg% /Protein

Net
Change

t50

f

10.37

9.97

- 0.35

- 0.90·

2

10.65

9.74

- 0.82

-

1. 37

12.0

3

12.73

10. 19'

2.25

2.80

22.1

.4

12.01

10.06

-

1. 39

11. 6

1. 61 +- 0.41

13. 6

-

0.84

+

Mean - s. e.
(
rt

2

-

•"
?':'

1.1.12

9.38

- 2.22

-

2.77

25.0

2

11.06

9.61

-

1.22

1.77

16. 1

3

10.89

8.86

-

1.72

-

2.27

20.9

-

0.29

20.7

1.10

-

1.65

14.5

1. 22

-

1.77

15. 1

+

-

+

Mean - s. e.

8.8

f

Mean - s. e.
3

%
Change

- 2.25

+

1

11. 47

10.54

2

11.78

10.74

-

3

12.76

10.91

- 2.17

- 2.72

21.4

4

11.52

10.24

-

1.50

- 2.05

17.9

5

12.38

11.03

-

1. 56

-

2.11

17.9

2.06 - 0.18

17.2

-

+

r:.....--

-

.,
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TABLE VII

-

The Effect. of the Vehicle (0. 1 M -Acetic Acid) for the
-

Calcitonin Preparations on the Serum Calcium of Rats

:
,.

.

·,:

Ca mg%

:

Animal
No.

to

6.Ca mg%

<to

t50

t
~r

F

r·
.

Mean

+

-

t5o)

.

•
,

-

1

12.60

12.<)4

+ 0.34

2

12.31

13.26

+ 0.95

3

12.53

13. 12

+ o. 59

4

11.56

11.93

+ 0.37

5

10.78

11.27

+ 0.49
+
+ 0.55 - 0.11

s. e.

I

·.

- 56 !he Effect of High Magnesium Concentrations on the Synthesis of

-Calcitonin by Ovine Thyroid Slices.
This experiment was designed to determine whether the stimulation
· of calcitonin synthesis, observed when the glands were incubated in
Krebs-Ringer bicarbonate buffer containing high concentrations of calcium, was due to a specific or a non-specific effect of calcium.

For

this purpose the Krebs-Ringer bicarbonate buffer was prepared such
that the level of magnesium was increased eight times, and at the same
time the sum of the magnesium and calcium ions was approximately
equal to the sum of the calcium and magnesium ions in the KrebsRinger bicarbonate buffer containing high concentrations of calcium ..
Magnesium was chosen because its serum level is affected by parathyroid hormone- the same as is calcium and in some cases it seems to be
able to substitute for calcium; in fact, administration of magnesium is
followed by an increased elimination of skeletal-bound radioactive calcium (Clark and Geoffray, 1958); furthermore, in vitro (Schachter and
Rosen, 1959; Hendrix et al. 1963) and in vivo studies (Alcock and

..
~

.

Macintyre, i962) suggest that magnesium and calcium act as competitors
in inte.stinal absorption.
The procedures for incubations, isolation and assay of hypercalcemic activity were the same as those used for the demonstration of
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the effect of calcium.
*':.

In both preparations (Tables VIII and IX) there

is a small increase in hypocalcemic activity, but the difference of the
means is not significant.

Preparations incubated on the same day in

Krebs-Ringer bicarbonate buffer containing physiological, and high concentrations of magnesium are compared in Table X.

It is evident that

magnesium has very little effect on the synthesis of calcitonin; the
small increas_e in hypocalcemic activity may be due to the substitution
of magnesium for calcium in processes not involved with calcitonin

f·.

synthesis, thus fre~ing more calcium to exert its effect on the biosyn-

f:.

thesis of calcitonin.

f

•

The data is summarized in Table XI.

Effect of High Calcium Concentrations on the Release of Calcitonin from
Ovine Thyroid Slices.
The in vivo studies do not distinguish whether the increase in circulatiJ!.g calcitonin is a result of increased synthesis, enhanced release
or both.

To determine whether calcium affected the release of calci-

tonin, two gram quantities of ovine thyroid slices were· incubated in 50
ml Erlenmeyer flasks containing Krebs-Ringer bicarbonate buffer with
either physiological or high concentrations of calcium.
were carried on in an atmosphere of air at 37

0

The incubations

C for 4 hours and were

terminated by removing the tissue from the flasks.

The medium from

.

'

-

-
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TABLE VIII
H;y,eocalcemi c Activit;y of Calcitonin Pre:earations Isolated
from Slices Incubated in Krebs-Ringer Bicarbonate Buffer
\

Containing Ph;ysiological Concentrations of Magnesium .

.
Preparation_
;:

Animal
No.

1

6.Ca/10 µg
mgo/o I Protein

Ca mg%
to

t5o

1

10.75

10.44

-2

10.94

10.61

3

11.10

9. 9 5

•

-

0.96

9.0

- 0.49

-

1.04

9.6

-

-

2.21

19.9

+

,.

.
+
Mean .... s. e .

-

1.65

-

-

%
Change

- 0.41

Mean - s. e.

2

Net
Change

+

1.40 - 0.42

1

12.04

11.30

- 0.87

-

1. 42

11.8

2

11. 45

11. 22

- 0.27

-

o. 82

7.2

3

11. 97

11. 36

- 0.71

-

1.26

10.6

4

12.20

11.54

-

0.78

-

1.33

11.0

5

12.11

11.10

-

1.19

-

1.74

14.5

.

-

1.31

+ 0.15
-

-

-
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TABLE IX
Hypocalcemic Activit;y: of Calcitonin Pre;earations Isolated from
Ovine Th;y:roid Slices Incubated in Krebs-Ringer Bicarbonate
Buffer Containing High Concentrations of Magnesium.

Preparation

f

-

Animal
No.

Ca m'i!!'/o
to

6.Ca/10 µg
mg% /Protein

Net
Change

Change

- 1.64
.

- 2.19

-

19.9
12.2

t5o

1

f1.06

9. 82

2

10.93

10.34

-

0.77

-

1.32

-

3

11.13

10.15

-

1.31

-

1. 86

- 16.8

•

+

-

Mean - s. e.

z

-

+

Mean - s. e.

%

+

1.. 7 8 - 0.25

1

11.95

11.06

-

1.12

-

1.67

-

14.9

2

11. 59

11.04

-

0.70

-

1.25

-

10.8

3

12.84

11. 26

- 2.00

- 2.56

- 20.0

4

11.56

11.03

-

0.67

-

1.22

-

10.6

5

11.34

11. 69

- 0.82

-

1.37

-

11.7

-

+

1.61 - 0.24

r
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TABLE X

Hypocalcemic Activity of Calcitonin .Preparations Isolated from
Slices Incubated in Krebs- Ringer Bicarbonate Buff er Containing
Physiological or High Concentrations of Calcium and Magnesium

Net 6.Ca mg%

Animal
No.

Physiological

Hjgh Magnesium

High Calcium

1

- 1.43

- 1. 78

- 1.66

2

- 0.83

- 1. 25

- 1.78

3

- 1.27

- 2. 57

- 2.73

4

- 1.34

- 1.23

- 2.06

5

- 1.75

- 1. 38

- 2.12

+
- 1.31 - 0.15

+
- 1.62 - 0.25

+

Mean - s. e.

p

*

*Probability
a Student's

N. S.

- 2 .. 06 -:

o. 18

0.01 - 0.005

of the significance of the diff ere nee determined by use of

"t"

Test.
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TABLE XI
Summary of the Data on the Effect of Caleium
and Magnesium on the Synthesis of Calcitonin*

Net 6. Ca mg% (mean)
10 µg Protein

·.~-

--

;

++
++
High Ca
or Me-

Normal

Y'·

p **

+ 0.18
-

+

-

1

-

HC

0.18

2

-

H<;

-

+
2.25 ·- 0.29

0.15

3

-

HC

-

2.06

- o. 42.

1

-

HM

2

-

HM

1 - N

-

1. 02

2 - N

-

1.55

3 - N

-

1.31

1 - N

-

1.40

2 - N

- 1.. 31 +-

+

-

+

-

+

0.15

1.61

1.78

-

1.62

0.41

+ 0.18
+

-

- 0.05

0.1

0.05

0.01

- 0.005

0.25

. N.S.

+- 0.24

N. S.

* Explanation of Symbols.
N - Preparations obtained from slices incubated in Krebs-Ringer
bicarbonate buff er containing physiological concentrations of
calcium and magnesium.
HC

Preparations obtained from slices incubated in buffer containing
high concentrations of calcium.

HM - Preparations obtained from slices incubated in buffer·. containing
.high concentrations of magnesium.·
**Probability of .the significance of the difference of the means as determined by the use of a Student's "t" Test.

- 62 flask was assayed for hypocalcemic activity in two rats.
received 150 µl of incubation medium.

Each rat

The control rats received 150 µl

of normal or high calcium Krebs-Ringer bicarbonate buff er.

The

results are presented in Tables XII, XIII and XIV.
The adµlinistration of normal buffer, which contained 676 µg of
calcium, increased the blood calcium by 5. 7%.

The administration of

the high calcium buffer, which contained 2. 7 mg of calcium increased
the blood calcium by 4. 5%.

The difference observed between the two

groups is due to the response of the pnimal to the level of hypercalcemia
indu~ed
>

by the administration of the two buffers.

The high calcium

buffer produced a higher original hypercalcemia than when the normal
buffer was administered and consequently induced the production of
larger amounts of calcitonin, which in turn decreased the blood cal-

'::·

cium.

Another factor was probably involved; the hypercalcemia de-

~··.

••

pressed parathyroid function, which in turn decreased calcium mobilization from bone.

The combined effects resulted in a lesser plasma

calcium increase observed for those animals receiving higher doses of
calcium.
The administration of the incubation- medium containing physiological
concentrations of calcium (Table XII) decreased the plasma calcium by
O. 76 mg.

However, since calcium was injected with the medium it

·~
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TABLE XII
Effect of Krebs-Ringer Bicarbonate Buffer Containing Physiological
and High Concentrations of Calcium on the Plasma Calcium of Rats.

Physiological Buffer
r

Mean

+

-

Ca mg%

6.Ca mg%

Animal
No.

to

tso

1

11.20

11.03

-

2

11.06

11.69

+ 0.63

3

10.71

11.64

+ 0.93

4

10.56

• 1.1. 43

+ 0.87

5

10.51

11.35

+ 0.84

<tso - t 0 )
0.17

+
+ 0.62 - 0.12

s. e.

High Calcium Buffer

Mean

+-

·ca mg%

6.Ca mg%

Animal
No.

to

tso

<tso - t 0 )

i

10.32

11.30

+ 0.98

2

11.. 24

11.50

+ 0.26

3

10.93

11.74

+ 0.78

4

10.38

10;86

+ 0.48

s·

11.28

11. 24

-

s. e.

0.04

+
+ 0.49 - 0.10

- ' .

...

." . •. '" ., •. .;:. .'.

" . ,.

.. '": .' : .

" '~_, . ' . . ...

··'

~ ~ . : ',. ·>;·. ..

". - .

.' .

TABLE XIII
Serum Calcium Changes Induced by the Administration of Incubation
Medi.a Containing Physiological Concentrations of Calcium.

Flask
No.

6.Ca mg%

Ca mg%
to

t5o

2 5 µ.g Protein

1

10.83
10.01

9. 95
9.28

- 0.59
- 0.49

2

10.98
9.67

9.64
9.44

- 1.25
- 0,21

Net
Effect

%
Change

*

- 1,21
1. 11

11.2
11. 1

-

1.87
- 0.83

17.0
8.5

- 0.93
31

- o:

1.55
-- 0.93

15,1
9.9

•

10,29
9.33

9.15
8.95

4

11.09
10.52

10.11
9.12

- 0.74
- 1. 05

- 1.36
- 1.67

12.2
15,8

5

10.90

9.76

- 0.99

- 1.61

14.7

+

-

1.34

+ 0,08
-

*Obtained

12. 8

by adding the mean of the change of the blood calcium of the control to the change
of the blood calcium of each flask.

**Per

cent change from

.
plasma

•

calcium values at t 0 .

I

"'
~

3

Mean - s. e.

**

I

TABLE XIV

Serum Calcium Changes Induced bii: the Administration of Incubation
Media Containing High Cone entr ations of Calcium.

Flask
No,
1

6.Ca mg%

Ca mg%
to

t50

10. 39
10.70

2 5 µ.g Protein

9.51
9.24

- 0,82
- 1.36

9. 93
9.52

-

1,53
0.70

-

...
1.00
0:91

Net
Effect

*

%
Change **

- 1,31

-

1.85

12.7
17.3

-

2.02
1.19

17.3
11, 5

'

!

2

3

11. 70 .
10.33
10. 32
10.51

9.09
9.32
'

4

11. 08
11.19

'

!'

i

-

10.10

- 1.34

i

5

+

Mean - s. e.

11.60

- 1.1. 0175

9.21
10.11

'

PnysioJogi<pal
1.34 - 0.08

High Calcium
1.65 +
- 0.08

-

I

C1'
Ul

1.49
1.40

14.4
13.3

- 2.24
1. 50

20.2
13.4

- 1.83
.
- 1.65

15.7

+

- 0.08

15.2

p ***
0.05 - 0.01

*Obtained by adding the mean of the change of the blood calcium of the control {Table VI) to
the change of the blood calcium for each flask.
>~~~Per cent change from plasma calcium values at t .
. .
0
**~:~Probability of the significance of the difference determined by the use of a Student's "t" statistic.

I

- 66 should be taken into account.

By adding the change brought about by

the vehicle (Table XII) we obtained the net change in. plasma calcium,
i. 45 mg or 13. 6%.

The administration of the incubation media contain-

ing high calcium concentrations (Table XIV) decreased the serum calcium by 1. 17 mg.

The net change is 1. 68 mg or 15. 4%.

When the net

change obtained by administering normal and high calcium incubation
media are compared, we find that the difference of the means is statistically

significant~

indicating that the release of calcitonin is under the

direct influence of calcium.

Isolation and Purification of Galcitonin
To determine whether the hypocalcemic activity that was observed
~:,

was due to calcitonin and not to some other unknown factor, calcitonin
was isolated and purified.

200 grams of fresh glands were incubated

in 50 ml Erlenmeyer flasks.

Each flask contained 2. O grams of thyroid

sliqes, 10 ml of Krebs-Ringer bicarbonate buffer containing high concentrations of calcium and 2. 5 µCi of glycine-C-14 (UL).

The incubations

were· carried on in an atmosphere of air at 37° C for four hours.

After

the incubations were terminated with trichloroacetic acid, the slices
were minced and defatted.
urea-cysteine...:HCL

The defatted material was extracted with

The extract was dialyzed against O. 1 M acetate

- 67 buffer for 24 hours at 4

0

C.

The dialyzate was made 1. O M with 3. O

M NaCl and allowed to stand 72 hours at 4

0

C.

The inactive precipi-

tated protein was collected by centrifugation and discarded.

To the

supernatant was added solid NaCl to make a 2. O M solution and allowed
to stand 72 hours at 4

0

C.

The active precipitate was collected by

centrifugation and lyophilized.
The lyophilized mat.erial weighed 120 mg.

It was dissolved as

completely as possible in 6. 5 ml of O. 1 M formic acid and the mixture
centrifuged to remove suspended material.

-

4 ml of the supernatant was

applied to a 40 x 2. 5 cm column of Sephadex G-100 and eluted with O. 1
M formic acid.

Figure 5 shows the elution pattern, the radioactivity

and the protein content of each fraction as measured by the Lowry
method (1956).

The first 60 ml, the void volume, were discarded.

The absorption at 280 mµ gave only one well-defined peak; however,
when each fraction was analyzed for protein content by the Lowry
method three
protein peaks became evident.
\
.

.

The hypocalcemic activity

was confined entirely to the second protein peak.

Radioactivity was

high in the fractions containing hypocalcemic activity with 18, 000 DPM/
mg prbtein in fraction 6 and falling to 8, 000 DPM/mg protein in
fraction 10.
The fractions containing hypocalcemic activity were lyophilized

- 68 -

fractions collected.
{ '

t )•

Hypocalcemic activity indicated by horizontal bar

- 69 and 1. 3 mg of solid material was obtained.

600 µg of this material,

containing 456 µg of protein, were dissolved in O. 1 M acetic acid and
used for the assay 9f hypocalcemic activity.

This solution was diluted

f :50 with O. 1 M acetic acid and 250 µl of the diluted solution,

O. 56 µg protein, was injected into each rat.
of this material is shown in Table XV.
calcium is - O. 82 mg.

containing

The hypocalcemic activity

The average change in serum

When we add the change resulting from the

vehicle alone, which is + O. 56 mg we obtain a net effect of - 1. 38 mg
or an 11% drop in serum calcium.

From the definition of a unit, O. 56

•
µ.g of protein is equivalent to 11 milliunits and 1. 0 mg of protein is
equivalent to 19. 5 MRC units.
700 p.g of the material obtained by lyophilizing the fractions from
Sephadex G-100 containing hypocalcemic activity were dissolved in 350
µ.l of 1. O M formic acid and applied to a 45 x O. 9 cm column of
Sephadex G-50 superfine; it was then eluted with O. 1 M formic acid -

1. 0 M urea - O. 2 M NaCl.

The elution pattern is shown in Figure 6.

The hypocalcemic activity is confined to the main protein peak; radioactivity was associated mainly with the fractions containing the hypocalceffi:iC activity~

The active fractions were pooled and lyophilized.

The lyophilized material was dissolved in O. 1 M acetic' acid containing
0.1% albumin and assayed for hypocalcemic activity.

The albumin was

- 70 -

TABLE XV

Hypocalcemic Activity of Lyophilized Fractions
from the Sephadex G-100 Column.

Ca mg%

Animal
No.

to

tso
11.69

2

12.76
.
12.67

3

1

ti.Ca mgo/o

•

....
Net Effect ...
D.Ca mg/O. 56 µg
Protein

- 1.07

- 1.62

12.16

- 0.51

- 1.06

12.29

11.51

- 0.78

-

4

12.01

12.21

- 0.80

- 1.35

5

11.94

11.00

- 0.94

- 1.49

+

:

Mean - s. e.

*Obtained
.

1.33

+

- 1.37 - 0.09

by adding the mean of the change of the serum calcium of the

controls (Table VII) to the change of the serum calcium of each animal
that received the experimental preparation.
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FIGURE 6.

Elution pattern of hypocalcemic activity from a Sephadex

G-50 superfine column.

were collected.

Flow rate:

(

.... . ) .

1. O ml fractions

The hypocalcemic activity was eluted as a single peak

at fractions 16, 17 and 18.
expansion of the

6 ml per hour;

% T scale.

Hypocalcemic activity.
Protein content ( o ----- o ).

2x

Radioactivity

- 72 added to counteract the tendency of calcitonin to become adsorbed to
.

glass surface of the container (Parsons, 1967}.

140-170 gram rats

were injected with 200 JJ.l of the calcitonin. solution into the femoral
vein.

The control animals received 200 µl of the lyophilized eluent

used to elute calcitonin from the Sephadex G-50 column.
eluent was dissolved in O. 1 M
animals.

The lyophilized

acetic acid and administered to the

The hypocalcemic activity is shown in Table XVI.

O. 18 JJ.g of protein produces an

Since

11. 7% fall in calcium, it can be calcu-

lated that the potency of the purified.calcitonin is 66. 5 MRC units per
milligram protein.

,.

~

·

Characterization of the Purified Calcitonin
To assess the purity of the calcitonin obtained the individual
fractions (16, 17 and 18} containing hypocalcemic activity were chromatographed on a thin layer Eastman Chromatogram Sheet 6065 (cellulose
with fluorescent indicator) and developed with the upper phase of a
I

.

butanol: acetic acid: water (4:1:5) system for 2. 5 hours.

The protein

spots under short ultraviolet light (2 54 mµ) are visible as dark purple
spots on a yellow fluorescent background.

Only one spot for each

fraction was visible (Figure 7). and it appears that the protein in each
fraction is holl1:ogenous.

Since the spots of all three fractions had the

TABLE XVI
Hypocalcemic Activity of Lyophilized Fractions from Sephadex G-50 Superfine

Net Effect*
per o. 18 µg
Protein

++
Ca
mg% (t 0)
Control
Exper.

++
Ca
mg% (t 50 )
Control
Exper.

Control

Exper.

1

10.86

10.93

11,16

10.13

+ 0.42

- o. 80

- 1.26

11.5

2

10.57

10.55

11.26

9.93

+ o.69

- 0.62

- 1.39

13. 1

3

10.94

10.77

11.52

10,20

.+ 0.58

- 0.57

- 1.21

11.1

4

10. 76

10, 85

11.18

10,09

+ 0,30

- 0.76

- i,16

10,4

5

10,66

11.52

11.64

10.85

+ 0.98

-

o.67

- 1.35

12.5

+ 0.59

- o.68

- 1.27

11.7

Animal
No.

+
Mean - s. e.

*Obtained

t::i.Ca mg%

...

.

% Change

by adding the mean of the (!hange of the blood of the calcium of the control animals

to the change of the blood calciunJ;
·.,:r·. of eaiah
.._, .exp,,:rimental animal.
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Solvent Front
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FIGURE 7.

(18)

(17)

(16)

Reproduction of thin layer chromatogram of fractions

containing hypocalcemic activity eluted from Sephadex G-50

superfine~

The chromatogram, on Eastman cellulose sheet with fluorescein indiC,ator·
'I,·,

was developed in a butanol: acetic acid: water (4:1:5) system for
hours.

z•.Jf·.
""-'
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same

Rf

value (0.116) the protein in all three fractions is presumably

the same.
An aliquot of the combined fractions was subjected to two-dimensional chromatography.

The chromatogram was developed in one

direction with the upper phase of a butanol: acetic acid: water system
and in the other direction with a propanol: water (70 :30) system..

Since

only one spot was visible on the two-dimensional chromatogram (Figure
8), it appears that the preparation was homogenous.
To determine with certainty whether the protein was calcitonin or

•

not and whether it was contaminated by .other protein material 3. 0 µg
protein was hydrolyzed for 24 hours at 110° C in 6. O N HCl.

The

hydrolysate was evaporated to dryness in a flash evaporator. and twice
redissolved in water and dried again.

After the last drying it was

dissolved in 600 µl of O. 01 N HCl and analyzed for amino acids on a
TSM Amino Acid Auto analyzer.
amino acids.

Figure 9 shows the pattern of eluted

The absence of lysine and isoleucine are strong indica-

tions that the peptide is calcitonin.

The glycine peak was collected and

evaporated, almost to dryness, and diluted to 10 ml with water.

A 100

µl aliquot was measured for radioactivity and found to contain radioactivity.

- 76 Solvent Front

( 1)

. (2)

Origin

FIGURE 8.

Reproduction of two-dimensional chromatogram of lyophilized

hypocalcemic active fractions eluted from Sephadex G-50 superfine.

The

chromatogram on Eastman cellulose sheet was developed in direction 1
with a butanol: acetic acid: water (4:1:5) system and in direction
propanol: water (70:30) system.
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- 78 CHAPTER IV
DISCUSSION
From information provided by previously reported studies on the

i~

f
f
r.'

in vitro biosynthesis of several polypeptide hormones (Adiga et al. 1965;
Bauer and Lazarow, 1961; Mallory et al. 1964; Sacks, 1963; Steiner

!·

II

f~

,_.

F·"

and Oyer, 1967) it appeared likely that the biosynthesis of calcitonin
could be demonstrated in vitro.

To our knowledge, no attempts have

been made to demonstrate the synthesis of calcitonin.
In this study the composition

or the

incubation medium necessary

to give high incorporation of glycine-C-14 into the protein fraction of the
thyroid tissue was defined.

It was found that the addition of glucose

(320 mg/100 ml) to Krebs-Ringer bicarbonate buffer (pH 7.4) increased
incorporation markedly (200%).
biosynthesis.

Glucose acts as the energy source for

The addition of the 15 amino acids of calcitonin to the

Krebs-Ringer buffer had very little effect on the incorporation of label
in proteins.

In this instance, as was the case when no additions were

made, the lack of an energy source would limit biosynthesis and, thus,
the observed glycine-C-14 incorporation.

The addition of both glucose

and the 15 amino acids of calcitonin increased incorporation of glycineC-14 by 100%, less than when glucose alone was added.

The reason

for this inhibitory effect of the amino acids is not clear.

In all the

- 79 incubations the buffer which contained both glucose and amino acids was
used.

The inhibitory effect of the amino acids is possibly due to the

suppression of synthesis of thyroid proteins .in favor of the synthesis of
those peptides that contain only the exogenously added amino acids .
for the de novo synthesis of proteins would have to come from the
limited pool of free amino acids already existing in the tissue slices,
from breakdown of proteins and from gluconeogenesis, with the result
that many peptides and proteins would be synthesized.

When exogenous

amino acids were added the system would use these preferentially

•

resulting in the preferential synthesis of those proteins and peptides
made up of the exogenous amino acids, and since calcitonin is one of
these peptides its synthesis would be preferentially stimulated.
To demonstrate the synthesis of calcitonin, ovine thyroid glands
were incubated in Krebs-Ringer bicarbonate buffer for 4 hours at 37

0

C.

After incubation the slices were defatted and extracted with 10 volumes
of 8. 0 M urea - O. 1 M cysteine in O. 2 N HCI.

The urea-cysteine-HCl

system has been used with success in the extraction of calcitonin by
Potts et al. (1967).

For the isolation of calcitonin from the extract, the

method of Gudmundsson et al. (1966) was used.

Calcitonin was isolated

through the second sodium chloride precipitation step.

The precipitate

was lyophilized, dissolved in O. 1 M acetic acid and administered intra-

- 80 venously to 140-170 gram rats.

When the hypocalcemic activity of

incubated and non-incubated glands was compared, no difference was
observed.

Since calcitonin titers in the circulation seem to be con-

trolled by the blood calcium concentrations, the calcium concentration in
the media was increased in an attempt to stimulate calcitonin synthesis.
A four-fold increase in calcium markedly stimulates calcitonirt synthesis.
In Vivo studies by Gitte$ et al. (1968) have shown that the extractable
content of calcitonin in the thyroid gland is markedly reduced after
hypercalcemic stimulation.

-.-

Care et al. (1968), on the other hand, ob-

served no difference in the calcitonin content of the thyroids from pigs
subjected to hypercalcemia and from normal pigs.

Our results are in

disagreement with the findings of Gittes and Care.

The reason for the

conflicting results is due to the different methods used.

Both Gittes

and Care. made their measurements in vivo, where measurements of
the calcitonin content of the thyroid glands are complicated by the fact
that during the time of perfusion with high calcium synthesis may occur,
\

but it. may be masked by the continuous secretion and destruction of
the hormone at the target organ.
In an effort to determine whether the stimulation of calcitonin
synthesis was a specific effect of calcium or whether magnesium could
substitute for calcium, the concentration of magnesium was ·:Picifeased in

- 81 -

such a way that the ionic strength of the high calcium and high magnesium
media were the same.

Magnesium was chosen because about 60% of the

total body magnesium is located on the surface of bone, incapable of
penetration into the lattiCe interior.

It exchanges for calcium in bone on

a mole-for-mole basis (Blaxter, 1956).

It has also been shown that the

levels of serum and urinary magnesium are controlled by parathyroid hormone in a manner

simil~r

to that of calcium (Bethune et al. 1968).

The

results of this study show that magnesium did not significantly affect
the synthesis of calcitonin, therefore,,,. the mechanism by which calcium
stimulates the synthesis of calcitonin is· not affected by magnesium.

The

molecular basis for the calcium activation of the synthesis of this particu~
~

f- ••

'~;

lar peptide is completely unknown.

It may increase the uptake of amino

acids by the cells; in the parathyroid it has been shown to decrease the
uptake of the amino acid analog o.-aminoisobutyric acid (Raisz and
0 1 Brien, 1963).

Further studies would be needed to establish how cal-

cium brings about its effect.
\

When calcitonin is injected into rats it produces hypocalcemia
which starts a few minutes after administration of the hormone and
reaches a maximum at about one hour and returns to normal within
three hours (Kumar et al. 1965; Hirsch et al. 1964).

It has been

demonstrated both in vivo (Milhaud et al. · 1965b;. Martin et al. 1966) and
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in vitro (Friedman and Raisz, 1965; Aliapoulios et al. 1966) that calcitonin produces its hypocalcemic response by inhibiting bone resorption.
Macintyre (1967) has shown that the hormone is biologically active on
isolated, perfused cat tibia proving that the effect is a direct one.

The

mechanism that controls the titer of the circulating hormone seems to
be similar to that controlling parathyroid hormone.

Secretion of para-

thyroid hormone has been shown to be controlled by blood calcium con centration; hypocalcemia enhancing ·secretion and hypercalcemia abolishing
secretion (Sherwood et al. 1968).
dependent upon blood calcium.

Calcitonin has also been shown to be

Work by Care et al. (1967) indicated

that the secretion of calcitonin was controlled by a negative feedback
which operated through the blood calcium concentration.

Care et al.

(1968) measured the secretion of calcitonin in pigs in vivo and were able
to demonstrate that there was a linear relationship between calcitonin in
the venous blood and the concentration of calcium in the perfusing
medium over a range of calcium of 6-10 meq/liter.
of calcium they were not able to detect calcitonin.

Below 6 meq/liter
Lee et al. (1969)

have shown that calcitonin is secreted at normal blood calcium concentra. tions and even below.

The manner by which calcium controls the

secretion rate of calcitonin is unclear.

It could act directly on the

secretion granules of the C cells or its action may be mediated by an un -
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,

known messenger.

Gittes and Irvin (1965) suggested that a parathyroid

factor may have been responsible for release of calcitonin; subsequent
studies, however, f!'liled to confirm their hypothesis (Foster, 1968;
Toverud et al. 1966).

Control of calcitonin secretion by the pituitary

gland has been investigated and there is no evidence of such a control
(Milhaud and Mauktar, 1965).

Recently Avioli et al. (1968) have found

that calcitonin is released by glucagon.

The results obtained in this

investigation support the hypothesis that calcium exerts a direct effect
on the release of calcitonin from the thyroid gland; in fact, an increase

•

in the concentration of calcium in the incubation media led to an increase in the release of the hormone.

From the data obtained, it can

be calculated that the glands incubated in Krebs-Ringer buffer containing
a high calcium concentration, 500 MRC milliunits, of calcitonin were
released per gram of glands per 4 hours.

·The glands incubated in

buffer containing physiological. concentrations of calcium released 442
MRC milliunits calcitonin per gram per 4 hours.
\

Since the hypocalcemic effect observed upon administration of the
calcitonin preparations may have been the result of some unknown impurity,_ the hormone was purified.

For purification the method of

Gudmundsson et al. (1966) was used. · The lyophilized material, obtained
by precipitation in 2. O M NaCl, was dissolved in O. 1 M formic acid

- 84 -

and applied to a Sephadex G-100 column.

The fractions containing

hypocalcemic activity were combined and lyophilized.

The lyophilized

material was found to have very high biological activity; O. 56 µg protein
lowered the serum calcium of rats by 11% which corresponds to 11 MRC
milliunits activity by definition; it can be calculated that the activity of
this fraction was 19. 5 MRC units per mg protein.

700 µg of the

lyophilizate was dissolved in 0. 35 ml of 1. O M formic acid and applied
to a 45 x O. 9 mm column of Sephadex G-50 superfine.
mic activity was found in fractions 16, 17 and 18.

•

fractions comprised the main protein peak.

The hypocalce-

These three

These fractions were com-

(
~

bined and lyophilized and the hypocalcemic activity assayed.

It was

found that O. 18 µg of protein decreased the serum calcium of rats by
12%, which is equivalent to 12 MRC milliunits ·activity or 66. 7 MRC
units per milligram protein.

The activity of chemically synthesized

calcitonin is much higher. about 200 MRC per milligram.

The lower

activity of our preparation is possibly due to denaturation which
occurred during isolation and purification, or to species differences.
The protein in all three fractions was homogenous on thin layer
chromatography and the Rf value was the. same, indicating that the protein was identical in the three fractions.

An aliquot of the pooled

fractions was found to be homogenous on two-dimensional thin layer

- 85 -

.

chromatography.

Amino acid analysis of an aliquot of the combined

fractions was found to lack both lysine and isoleucine and since porcine
calcitonin lacks these two amino acids, it is further proof that calcitonin was actually isolated and purified, and that the hypocalcemic
activity observed was due to calcitonin and not to some other unknown
agent.
1~

However, the possibility that ovine calcitonin

has an amino

acid composition different than porcine calcitonin should be considered,
since human calcitonin has been found to have many amino acid residues
which are not found in the porcine hormone (Neher et al. 1968) .

•

The possibility that calcitonin can· be synthesized in an in vitro
system opens the way for further studies.

The hormone with a radio-

active label can be used to trace the locus of action at the cellular
level at the target organs.

The mechanism and the site of synthesis

can be studied by the use of protein synthesis inhibitors and cellular
fractionation.

Since the hormone is present in granules in the C cells

it would be of interest to study the locus of synthesis and the transport of the hormone to the granules.

Another aspect of calcitonin

synthesis amenable to study with the system developed in this investiga·tion is. whether the hormone is

synthesiz~d

as a 32 amino acid poly-

peptide or whether it has a precursor molecule, and if so, when and
how it is transformed into the biologically active polypeptide which is
found in the thyroid glands.

- 86 CHAPTER V
SUMMARY AND CONCLUSIONS
Recently the in vitro biosynthesis of polypeptide hormones has
been reported.

In this investigation was presented a method for the

biosynthesis of calcitonin in ovine thyroid slices.

Ovine thyroid tissue

is contaminated with the inferior parathyroid tissue, whereas the
{.

-

superior parathyroids are anatomically separated.

We did not attempt

to separate the parathyroid .tissue, since the calcitonin synthesizing

• a,nd in some species to the
cells are "adventitious" to the thyroid
parathyroids and thymus (Macintyre, 1968); furthermore, since it is
now well established that there is only one calcitonin it was thought that
if the sheep parathyroid tissue contained C cells the calcitonin synthesized
by these cells would not interfere with the purpose of our work.

The

biosynthesis of the hormone opens the way for studies on the mechanism
and control of synthesis and release of the hormone.
In this study it was attempted to establish the role played by

calcium in the regulation of synthesis and release of calcitonin.

It has

been shown that in vivo calcitonin increases in the serum of animals in
response to a hypercalcemic stimulus.

In vivo studies, however, cannot

discern whether the hypercalcemia increases synthesis, release or both.
The results presented in this investigation show that calcium increases
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both the synthesis and release of the hormone.

Other factors may

exist. and recently Avioli et al. (1968) has found evidence that glucagon
may release calcitonin from the thyroid glands.

If this is true the

effect of glucagon is probably not related to the calcium effect. since
calcium can act in vitro. and the effect is a specific property of the
calcium ion.

In fact. magnesium cannot substitute for calcium.

This

may have been anticipated since calcitonin does not affect magnesium
levels in the blood (Gitelman et al. 1965}.
The purified hormone was foundi to have very high specific activity.
approximately 67 MRC units per

m~ligram

protein.

The hormone was

found to be pure and homogenous by thin layer chromatography and
amino acid analysis.
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ABSTRACT

Abstract of the dissertation entitled "THE IN VITRO BIOSYNTHESIS
OF CALCITONIN" s.ubmitted by Nino Sorgente in partial fulfillment of
the requirements for the degree of Doctor of Philosophy, June, 1969.

Slices of ovine thyroid glands were incubated (4 hr.. 31° C) with
glycine-C-14 in Krebs-Ringer bicarbonate buffer (pH 7. 4) containing
glucose (320 mg/ 100 ml) and the amino acids of calcitonin (20 mg/l).
Calcitonin was isolated by sodium chloride precipitation from the
incubated slices. and the hypocalcerrtic activity assayed in 140-170 gram
rats fasted for 18 hours.

The hypocalcemic activity was expressed as

the. change in serum calcium between time O and 50 minutes per 10 or
25 µg protein of the calcitonin preparation.
The hypocalcemic activity of calcitonin isolated from glands
incubated in buffer containing physiological concentrations of calcium
(ii. 5 mg%) was not significantly different from the hypocalcemic activity

of calcifonin isolated from unincubated glands.

However, when the

h:ypocalcemic activity of calcitonin isolated from slices incubated in
buffer containing high concentrations of calcium (45. 6 mg%) was compared to the hypocalcemic activity of calcitonin isolated from slices
incubated in buffer containing physiological concentrations of calcium, it
was found that ·the hypocalcemic activity increased 50%.

An increase

in the magnesimn concentration of the buffer from 3. 7 mg% to 29. 8 mg%
had no significant effect on the hypocalcemic activity of the calcitonin
preparations.
To determine whether calcium had an effect on the release of
calcitonin from the glands, at the end of the incubation the media was
assayed for hypocalcemic activity.

A significant increase in hypocalcemic

activity was found in the incubation media containing high concentrations
of calcium as compared to the media containing physiological concentr.ations of calcium.
The calcitonin from incubated slices was isolated by sodium
chloride precipitation and purified by" pa.ssage of the isolated material on
columns of Sephadex G-100 and Sephadex G-50 superfine.

The purified

material was homogeneous on thin layer chromatography and contained
very high hypocalcemic activity (66. 5 MRC units per milligram protein).
The purified material was subjected to amino acid analysis, and it was
found to contain all amino acids of porcine calcitonin, except leucine,
phenylalanine and tyrosine.

The glycine peak was collected and was

\

found to 'contain radioactivity.
In this work, a method for the biosynthesis of calcitonin in ovine thyroid slices was developed.

Using this method it has been shown that both the

synthesis and release of calcitonin are under the control of calcium ions.
Magnesium ions cannot substitute for calcium to stimulate the synthesis of
calcitonin.
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